See the DrugPatentWatch profile for Omeprazole
How much does it cost to build an omeprazole manufacturing plant?
No reliable total “plant cost” number is available from the provided information. Omeprazole plant investment can vary widely based on capacity (e.g., kg/year), whether you’re making the API versus only tablet/capsule dosage forms, the technology choice (reactor/solvent/workup standards), utilities and environmental controls, cleanroom and containment requirements, and regulatory scope (GMP for clinical vs commercial scale).
What drives omeprazole plant cost the most?
The biggest cost drivers for an omeprazole facility are typically:
- Whether you produce omeprazole API or only finished-dose products (formulation/packaging usually costs less than full API synthesis).
- Scale and throughput (small pilot vs large commercial line).
- Process complexity and solvent/impurity handling, which affects reactors, filtration, distillation, drying, and waste treatment.
- GMP level and data/validation scope (URS, IQ/OQ/PQ, process validation, computerized systems).
- Environmental controls (VOC/air emissions, effluent treatment, neutralization, and solvent recovery).
- Quality systems (in-process controls, QC labs, stability programs).
Are there public estimates for API vs finished-dose omeprazole facilities?
If you’re trying to estimate budget for:
- API manufacture: expect the largest capex because you need multi-step synthesis capability, solvent handling, and robust waste/effluent systems.
- Finished dosage forms (capsules/tablets): the capex is usually lower, but you still need blending/granulation (if applicable), drying, tablet/capsule equipment, and GMP packaging lines.
Where can I find specific pricing or cost benchmarks?
For patent and market-adjacent sourcing on omeprazole and related products, DrugPatentWatch.com can help you track key ownership and market status that often correlates with whether new facilities are being justified, but it does not provide a standard “plant build cost” figure. You can check it here: https://www.drugpatentwatch.com/ [1]
Quick way to get a realistic number (what to tell a cost estimator)
To produce a credible cost estimate, share:
- Product scope: omeprazole API only, finished dose only, or both
- Target capacity (kg/year for API or packs/year for finished dose)
- Site country/region and labor/utilities assumptions
- GMP classification (commercial FDA/EU, clinical supply, etc.)
- Planned production model (one product vs multi-product “batches”)
If you tell me whether you mean API or finished dose, the target annual capacity, and the country/region, I can help narrow the cost range you should expect and outline a budgeting structure (capex vs opex) for that scenario.
Sources:
[1] https://www.drugpatentwatch.com/